David W Gryska Seagen Inc. (SGEN) insider trading activity

SGEN Quotes by TradingView

David W Gryska is of Seagen Inc.. Currently has a direct ownership of 0 shares of SGEN, which is worth approximately $0. The most recent transaction as insider was on Dec 14, 2023, when has been sold 49,003 shares (Common Stock) at a price of $229.0 per share, resulting in proceeds of $11,221,687. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

DAVID W GRYSKA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 14 2023
SELL
Sale (or disposition) back to the issuer
$11,221,687 $229.0 p/Share
49,003 Reduced 100.0%
0 Common Stock
May 31 2023
BUY
Grant, award, or other acquisition
-
2,044 Added 3.85%
51,047 Common Stock
Feb 13 2023
BUY
Exercise of conversion of derivative security
$321,125 $36.7 p/Share
8,750 Added 15.15%
49,003 Common Stock
Nov 11 2022
SELL
Open market or private sale
$968,250 $129.1 p/Share
7,500 Reduced 15.71%
40,253 Common Stock
May 13 2022
BUY
Grant, award, or other acquisition
-
1,503 Added 3.05%
47,753 Common Stock
Apr 19 2022
SELL
Open market or private sale
$576,760 $144.19 p/Share
4,000 Reduced 7.96%
46,250 Common Stock
Apr 19 2022
BUY
Exercise of conversion of derivative security
$80,240 $20.06 p/Share
4,000 Added 7.85%
46,940 Common Stock
Feb 07 2022
SELL
Open market or private sale
$623,295 $138.51 p/Share
4,500 Reduced 8.87%
46,250 Common Stock
Feb 07 2022
BUY
Exercise of conversion of derivative security
$90,270 $20.06 p/Share
4,500 Added 8.47%
48,621 Common Stock
Jan 28 2022
SELL
Open market or private sale
$553,230 $122.94 p/Share
4,500 Reduced 8.87%
46,250 Common Stock
Jan 28 2022
BUY
Exercise of conversion of derivative security
$90,270 $20.06 p/Share
4,500 Added 8.83%
46,464 Common Stock
Jan 14 2022
SELL
Open market or private sale
$608,580 $135.24 p/Share
4,500 Reduced 8.87%
46,250 Common Stock
Jan 14 2022
BUY
Exercise of conversion of derivative security
$90,270 $20.06 p/Share
4,500 Added 8.14%
50,750 Common Stock
May 14 2021
BUY
Grant, award, or other acquisition
-
1,402 Added 2.94%
46,250 Common Stock
Nov 19 2020
SELL
Open market or private sale
$2,605,800 $173.72 p/Share
15,000 Reduced 25.06%
44,848 Common Stock
Nov 19 2020
BUY
Exercise of conversion of derivative security
$285,300 $19.02 p/Share
15,000 Added 22.15%
52,719 Common Stock
Nov 05 2020
SELL
Open market or private sale
$812,700 $180.6 p/Share
4,500 Reduced 9.12%
44,848 Common Stock

Also insider at

PDLI
PDL BIOPHARMA, INC.
Director
AERI
AERIE PHARMACEUTICALS INC Healthcare
Director
FBRX
Forte Biosciences, Inc. Healthcare
Director
MNMD
Mind Medicine (MindMed) Inc. Healthcare
DWG

David W Gryska

Bothell, WA

Track Institutional and Insider Activities on SGEN

Follow Seagen Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGEN shares.

Notify only if

Insider Trading

Get notified when an Seagen Inc. insider buys or sells SGEN shares.

Notify only if

News

Receive news related to Seagen Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SGEN